Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a

Abstract

The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.

Keywords

• Coronavirus disease 2019
• Pegylated interferon alfa 2a
• Interferons
• SARS-CoV-2